-
Lenvatinib, sold
under the
brand name
Lenvima among others, is an anti-cancer
medication for the
treatment of
certain kinds of
thyroid cancer and for other...
- baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib,
lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin.
BEACON Medicare...
-
breast cancer Iomeron (iomeprol) - Non-ionic
contrast medium Lenvima (
lenvatinib) -
Thyroid Cancer or
Kidney Cancer Leqembi (lecanemab) - Alzheimer's disease...
-
Vandetanib L01EX05
Regorafenib L01EX06
Masitinib L01EX07
Cabozantinib L01EX08
Lenvatinib L01EX09
Nintedanib L01EX10
Midostaurin L01EX11
Quizartinib L01EX12 Larotrectinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
- can also be used in the
treatment for
breast cancer and
kidney cancer.
Lenvatinib and
vandetanib are used for the
treatment of
progressive and
locally advanced...
-
Kinase inhibitors:
Agerafenib Avapritinib Axitinib Crenolanib Imatinib Lenvatinib Masitinib Motesanib Nintedanib Pazopanib Radotinib Quizartinib Ripretinib...
- also co-led with
Robert Motzer the
development of the
combination of
Lenvatinib+pembrolizumab
which was FDA
approved in
August 2021.
Later that year,...
